Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Sales | 166,126 | 155,976 | 141,569 | 125,834 | 117,578 |
| Cost of Goods | 19,228 | 20,222 | 16,495 | 13,721 | 13,999 |
| Gross Profit | 146,898 | 135,754 | 125,074 | 112,113 | 103,579 |
| Operating Expenses | 106,893 | 90,946 | 82,856 | 80,509 | 74,008 |
| Operating Income | 40,233 | 45,030 | 42,713 | 32,325 | 30,570 |
| Interest Expense | 198 | 174 | 162 | 158 | 210 |
| Other Income | 791 | -608 | 56 | -84 | -287 |
| Pre-tax Income | 40,826 | 44,248 | 42,607 | 32,083 | 30,073 |
| Income Tax | 13,996 | 17,798 | 14,734 | 10,310 | 9,139 |
| Net Income Continuous | 26,830 | 26,450 | 27,873 | 21,773 | 20,934 |
| Net Income | $26,830 | $26,450 | $27,873 | $21,773 | $20,934 |
| EPS Basic Total Ops | 0.15 | 0.14 | 0.16 | 0.12 | 0.12 |
| EPS Basic Continuous Ops | 0.15 | 0.15 | 0.16 | 0.12 | 0.12 |
| EPS Diluted Total Ops | 0.14 | 0.14 | 0.15 | 0.12 | 0.12 |
| EPS Diluted Continuous Ops | 0.14 | 0.14 | 0.15 | 0.12 | 0.11 |
| EBITDA(a) | $44,660 | $48,200 | $46,905 | $36,601 | $34,724 |